HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nancy J Edwards Selected Research
Nancy J Edwards Research Topics
Disease
5
Ischemic Stroke
12/2020 - 02/2012
5
Hematoma
05/2018 - 04/2015
4
Cerebral Hemorrhage
06/2019 - 01/2017
3
Stroke (Strokes)
01/2020 - 08/2015
2
Rupture
06/2019 - 02/2012
2
Hypertension (High Blood Pressure)
01/2018 - 12/2017
2
Hemorrhage
01/2018 - 12/2017
2
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2017 - 01/2017
2
Intracranial Aneurysm (Cerebral Aneurysm)
12/2017 - 02/2012
2
Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2017 - 02/2012
2
Aneurysm (Aneurysms)
12/2017 - 02/2012
2
Edema (Dropsy)
11/2017 - 10/2016
1
Myocardial Infarction
12/2020
1
Fibrosis (Cirrhosis)
01/2018
1
Coronary Artery Disease (Coronary Atherosclerosis)
12/2017
1
Thromboembolism
12/2017
1
Ruptured Aneurysm
12/2017
1
Dyslipidemias (Dyslipidemia)
12/2017
1
Brain Injuries (Brain Injury)
01/2017
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017
1
Nervous System Diseases (Neurological Disorders)
01/2017
1
Inflammation (Inflammations)
01/2017
1
Horner Syndrome (Horner's Syndrome)
04/2016
1
False Aneurysm (Pseudoaneurysm)
04/2016
1
Vasculitis (Vasculitides)
01/2016
1
Ischemia
08/2015
1
Gaucher Disease (Gaucher's Disease)
05/2008
1
Spinal Cord Diseases
10/2007
1
Subacute Combined Degeneration
10/2007
1
Paraplegia (Spastic Paraplegia)
10/2007
1
Ataxia (Dyssynergia)
10/2007
Drug/Important Bio-Agent (IBA)
3
Biomarkers (Surrogate Marker)
IBA
06/2019 - 11/2017
3
Cytokines
IBA
01/2018 - 08/2015
2
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2020 - 02/2012
2
Matrix Metalloproteinases (MMPs)
IBA
06/2019 - 01/2018
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
12/2020
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
12/2017
1
Interleukin-10 (Interleukin 10)
IBA
01/2017
1
Thrombin
FDA Link
10/2016
1
Free Radicals
IBA
10/2016
1
Iron
IBA
10/2016
1
Interleukin-4 (Interleukin 4)
IBA
08/2015
1
sulforaphane
IBA
04/2015
1
Transcription Factors (Transcription Factor)
IBA
04/2015
1
Glucosylceramidase (Glucocerebrosidase)
IBA
05/2008
1
Copper
IBA
10/2007
Therapy/Procedure
1
Length of Stay
05/2018
1
Therapeutics
12/2017
1
Aftercare (After-Treatment)
04/2016
1
Stents
04/2016
1
Highly Active Antiretroviral Therapy (HAART)
01/2016
1
Critical Care (Surgical Intensive Care)
01/2013
1
Contraindications
02/2012
1
Enzyme Replacement Therapy
05/2008